Certified by Founder Lodge
Novo Holdings
Denmark - Hellerup, Gentofte
INVESTOR
1 Disclosed Funding Rounds $50,000,000
34 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Novo Holdings is a holding and investment company, responsible for managing the operating and financial assets of the Novo Nordisk Foundation.
Headquartered in Copenhagen and wholly owned b
Company | Date | Round | Raised |
---|---|---|---|
Avalyn Pharma Inc. | September, 28 ,2023 | Series C | $175,000,000 |
MEDGENOME | September, 03 ,2022 | Unknown | $50,000,000 |
Hemab Therapeutics | February, 22 ,2023 | Series B | $135,000,000 |
MapLight Therapeutics, Inc. | October, 31 ,2023 | Series C | $225,000,000 |
Qure.ai | March, 29 ,2022 | Series C | $40,000,000 |
Hoba Therapeutics | December, 12 ,2023 | Series A | $24,800,000 |
AMSilk GmbH | Biotech Materials | April, 05 ,2023 | Unknown | $27,344,000 |
Nalu Medical, Inc. | January, 05 ,2024 | Unknown | $65,000,000 |
Ray Therapeutics, Inc. | May, 17 ,2023 | Series A | $100,000,000 |
Cleveland Diagnostics, Inc. | January, 18 ,2024 | Unknown | $75,000,000 |
Octave | June, 16 ,2023 | Series C | $52,000,000 |
Elo Life Systems | January, 25 ,2024 | Series A | $20,500,000 |
Halodoc | August, 02 ,2023 | Series D | $100,000,000 |
CARPL - Radiology AI Platform | February, 02 ,2024 | Unknown | $6,000,000 |
Bactolife | August, 14 ,2023 | Series A | $30,000,000 |
Avalyn Pharma Inc. | September, 28 ,2023 | Series C | $175,000,000 |
Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
MapLight Therapeutics, Inc. | October, 31 ,2023 | Series C | $225,000,000 |
Myricx Bio | July, 09 ,2024 | Series A | $115,246,800 |
Hoba Therapeutics | December, 12 ,2023 | Series A | $24,800,000 |
F2G | September, 13 ,2024 | Unknown | $100,000,000 |
Nalu Medical, Inc. | January, 05 ,2024 | Unknown | $65,000,000 |
Booster Therapeutics | October, 11 ,2024 | Seed | $15,000,000 |
Cleveland Diagnostics, Inc. | January, 18 ,2024 | Unknown | $75,000,000 |
Elo Life Systems | January, 25 ,2024 | Series A | $20,500,000 |
AvenCell | October, 22 ,2024 | Series B | $112,000,000 |
CARPL - Radiology AI Platform | February, 02 ,2024 | Unknown | $6,000,000 |
Adcendo | November, 26 ,2024 | Series B | $135,000,000 |
Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
Myricx Bio | July, 09 ,2024 | Series A | $115,246,800 |
F2G | September, 13 ,2024 | Unknown | $100,000,000 |
Booster Therapeutics | October, 11 ,2024 | Seed | $15,000,000 |
AvenCell | October, 22 ,2024 | Series B | $112,000,000 |
Adcendo | November, 26 ,2024 | Series B | $135,000,000 |